| Literature DB >> 30383781 |
Andrew Mitchelmore1, Lee Stoner2, Danielle Lambrick3, Lucy Sykes4, Charlotte Eglinton4, Simon Jobson1, James Faulkner1.
Abstract
BACKGROUND: This study examined the short-term reproducibility of non-invasive estimates of central and peripheral blood pressure and markers of central systolic loading (augmentation index [AIx; a measure of central systolic loading] and AIx75 [AIx standardised to 75 b·min-1 heart rate]) and the effect of posture and fasting state on these variables in patients with acute stroke.Entities:
Mesh:
Year: 2018 PMID: 30383781 PMCID: PMC6211701 DOI: 10.1371/journal.pone.0206329
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Consort statement.
Participant demographic data.
| % | |||
|---|---|---|---|
| 22 | |||
| 72.3 ±10.4 | |||
| Male | 16 | 73 | |
| Female | 6 | 27 | |
| European | 22 | 100 | |
| Small vessel lacunar | 2 | 9 | |
| Partial anterior circulation stroke | 8 | 36 | |
| Total anterior circulation stroke | 3 | 14 | |
| Posterior circulation stroke | 1 | 5 | |
| Intracerebral haemorrhage | 6 | 27 | |
| Undetermined | 2 | 9 | |
| Myocardial infarction | 9 | 41 | |
| Heart surgery | 1 | 5 | |
| Stent | 0 | 0 | |
| Catheter | 1 | 5 | |
| Heart defect | 1 | 5 | |
| Stroke | 7 | 32 | |
| Hypertension | 10 | 45 | |
| High cholesterol | 6 | 27 | |
| Diabetes | 0 | 0 | |
| Coronary artery disease/heart failure | 5 | 23 | |
| Atrial Fibrillation | 8 | 36 | |
| Thyroid disease | 2 | 9 | |
| Lung disease | 0 | 0 | |
| Asthma | 0 | 0 | |
| Cancer | 2 | 9 | |
| Kidney disease | 1 | 5 | |
| Hepatitis | 2 | 9 | |
| Current smoker | 2 | 9 | |
| Previous smoker | 6 | 27 | |
| Current alcohol drinkers | 17 | 77 | |
| Current weight loss plan | 1 | 5 | |
| Sedentary | 3 | 14 | |
| Lightly active | 3 | 14 | |
| Moderately active | 15 | 68 | |
| Vigorously active | 1 | 5 | |
| Statins | 2 | 9 | |
| Anti-thrombotic | 14 | 64 | |
| Diuretics | 1 | 5 | |
| Calcium blockers | 5 | 23 | |
| Alpha blockers | 1 | 5 | |
| Beta blockers | 5 | 23 | |
| Anticoagulants | 1 | 5 | |
| Other anti-hypertensive medication | 5 | 23 | |
| ACE-I | 4 | 18 | |
| ARB | 2 | 9 |
Abbrevations: ACE-I–Angiotensin-converting-enzyme inhibitor, ARB–Angiotensin II receptor blockers, CVD–Cardiovascular disease
Short-term reproducibility of SphygmoCor XCEL in measuring peripheral and central haemodynamic variables.
| Supine-F | Supine-NF | Seated-F | Seated-NF | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICC | SEM | SDC | ICC | SEM | SDC | ICC | SEM | SDC | ICC | SEM | SDC | |
| MAP (mmHg) | 0.88 | 4.6 | 12.7 | 0.81 | 5.6 | 15.4 | 0.83 | 5.1 | 14.3 | 0.84 | 5.8 | 16.0 |
| SBP (mmHg) | 0.84 | 7.3 | 20.4 | 0.84 | 7.8 | 21.7 | 0.83 | 7.3 | 20.3 | 0.85 | 7.6 | 21.1 |
| DBP (mmHg | 0.89 | 3.6 | 9.9 | 0.80 | 4.5 | 12.5 | 0.82 | 4.5 | 12.5 | 0.81 | 5.3 | 14.6 |
| PP (mmHg) | 0.80 | 5.4 | 15.1 | 0.89 | 4.9 | 13.5 | 0.77 | 5.8 | 16.2 | 0.82 | 5.7 | 15.9 |
| cSBP (mmHg) | 0.85 | 6.3 | 17.4 | 0.83 | 7.0 | 19.4 | 0.81 | 6.3 | 17.5 | 0.83 | 7.0 | 19.4 |
| cDBP (mmHg) | 0.90 | 3.5 | 9.7 | 0.82 | 4.4 | 12.2 | 0.83 | 4.4 | 12.2 | 0.83 | 5.1 | 14.2 |
| cPP (mmHg) | 0.84 | 4.1 | 11.4 | 0.88 | 3.8 | 10.4 | 0.79 | 4.5 | 12.6 | 0.83 | 4.3 | 11.9 |
| Heart rate (b·min-1) | 0.89 | 3.3 | 9.2 | 0.83 | 4.4 | 12.3 | 0.88 | 3.8 | 10.6 | 0.85 | 4.0 | 11.0 |
| AP (mmHg) | 0.76 | 2.8 | 7.8 | 0.66 | 3.0 | 8.4 | 0.72 | 3.5 | 9.7 | 0.71 | 2.9 | 8.1 |
| AIx (%) | 0.81 | 3.7 | 10.3 | 0.66 | 5.1 | 14.0 | 0.78 | 5.1 | 14.2 | 0.73 | 5.1 | 14.1 |
| AIx75 (%) | 0.81 | 4.7 | 12.9 | 0.70 | 5.6 | 15.4 | 0.78 | 6.2 | 17.1 | 0.74 | 5.8 | 16.1 |
Abbrevations: Abbreviations: AIx—Augmentation Index, AIx75—Augmentation Index @ 75bpm, AP = Augmented Pressure, cDBP—Central Diastolic Blood Pressure, cPP—Central Pulse Pressure, cSBP—Central Systolic Blood Pressure, DBP—Diastolic Blood Pressure, F–Fasted, ICC–Intraclass Correlation Coefficient, MAP—Mean Arterial Pressure, NF—Non-Fasted, SDC–Smallest Detectable Change, SEM–Standard Error of Measurement, SBP—Systolic Blood Pressure
Mean and SD for peripheral and central haemodynamic variables.
| Total | Supine | Seated | Interaction | Posture | Fasted | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fast | Non | Fast | Non | η2p | η2p | η2p | ||||||
| MAP (mmHg) | 100 | 104 | 94 | 106 | 97 | .86 | .00 | .34 | .52 | |||
| SBP (mmHg) | 142 | 147 | 137 | 148 | 138 | .82 | .00 | .09 | .14 | .48 | ||
| DBP (mmHg) | 79 | 82 | 74 | 85 | 76 | .90 | .00 | .43 | .53 | |||
| PP (mmHg) | 64 | 65 | 63 | 64 | 62 | .57 | .02 | .33 | .05 | .20 | ||
| cSBP (mmHg) | 130 | 135 | 123 | 137 | 124 | .82 | .03 | .06 | .16 | .59 | ||
| cDBP (mmHg) | 80 | 83 | 75 | 86 | 78 | .95 | .00 | .43 | .50 | |||
| cPP (mmHg) | 49 | 52 | 48 | 51 | 47 | .71 | .01 | .06 | .16 | .55 | ||
| Heart rate (b·min-1) | 68 | 65 | 68 | 66 | 71 | .30 | .05 | .19 | .60 | |||
| AP (mmHg) | 16.2 | 18.8 | 14.9 | 17.5 | 13.7 | .65 | .01 | .22 | .61 | |||
| AIx (%) | 31.9 | 35.5 | 30.3 | 33.5 | 28.4 | .97 | .00 | .22 | .43 | |||
| AIx75 (%) | 28.2 | 30.7 | 27.2 | 28.7 | 26.4 | .54 | .02 | .08 | .14 | .20 | ||
Abbrevations: Abbreviations: AIx—Augmentation Index, AIx75—Augmentation Index @ 75bpm, AP = Augmented Pressure, cDBP—Central Diastolic Blood Pressure, cPP—Central Pulse Pressure, cSBP—Central Systolic Blood Pressure, DBP—Diastolic Blood Pressure, F—Fasted, N—Non-Fasted, MAP—Mean Arterial Pressure, PP–Pulse Pressure, SBP—Systolic Blood Pressure. Bolded P < .05